TABLE OF CONTENTS INTRODUCTION 2

First Page		Document Content
Date: 2015-06-19 09:17:51 Immunology Immunosuppressants Monoclonal antibodies Autoimmune diseases Biotechnology Infliximab Tumor necrosis factor alpha TNF inhibitor Adalimumab Etanercept Monoclonal antibody therapy Ankylosing spondylitis		TABLE OF CONTENTS INTRODUCTION 2 Add to Reading List Source URL: www.abirisk.eu Download Document from Source Website File Size: 756,10 KB Share Document on Facebook

	Biotechnology, BS "DBEFNJD.BQ 5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT DocID: 1xTqy - View Document
	PDF Document DocID: 1wroO - View Document
	Building A Better Mousetrap: Patenting Biotechnology In The European Community DocID: 1vr7C - View Document
	BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod DocID: 1vq6b - View Document
	Biotechnology Consultation Agency Response Letter BNF DocID: 1vpUZ - View Document